These poisoning thesis topics are intended for MD Medicine and DNB Medicine candidates planning clinically practical dissertation work in acute toxicology. The emphasis is on designs that can be completed within one thesis period using patients, bedside observations, routine toxicology-related laboratory tests, electrocardiography, arterial blood gas analysis and other investigations already available during standard care. Selection should favour a clearly defined exposure, a fixed assessment time point and outcomes that can be measured consistently across cases. The same framework can be adapted for poisoning research topics, an MD Medicine poisoning protocol or a DNB Medicine poisoning synopsis before final discussion with the postgraduate guide.
Last reviewed and updated: September 2026 · 2026–27 admissions
Our MD Medicine Thesis Guidance provides structured protocols, sample size formulas, and institutional review board (IRB) layout guides.
Not the general medicine subspeciality you need? Poisonings related for md medicine/dnb medicine is one section of our full general medicine collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.
Browse all General Medicine Thesis Topics →📌 Updated for 2026–2027 MD Medicine/DNB Medicine Poisoning admissions
The page has been reviewed for feasibility in Indian postgraduate departments where most poisoning research is based on emergency admissions, routine investigations and structured clinical observation.
Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:
Already have your thesis title?
Generate the full poisonings related for md medicine/dnb medicine protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.
Generate your protocolAlongside poisonings related for md medicine/dnb medicine protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.
Enquire on WhatsApp →Poisonings related for md medicine/dnb medicine research outside India
The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the poisonings related for md medicine/dnb medicine research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.
Board and residency programmes — country by country
Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the poisonings related for md medicine/dnb medicine research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.
United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a poisonings related for md medicine/dnb medicine research protocol for their programme and submit it for institutional review board approval before any data are collected.
Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A poisonings related for md medicine/dnb medicine IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.
Bahrain — NHRA. Trainees turning poisonings related for md medicine/dnb medicine research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.
Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the poisonings related for md medicine/dnb medicine research proposal is the document assessed at the start of it.
Kuwait — KIMS. A poisonings related for md medicine/dnb medicine study protocol goes to the institutional committee for approval before the project begins.
Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the poisonings related for md medicine/dnb medicine proposal follows the same structure throughout.
Postgraduate degrees — Malaysia, the Gulf and beyond
Malaysia — MMed, the National Medical Research Register and MREC. A poisonings related for md medicine/dnb medicine dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.
PhD and Master's candidates elsewhere. University programmes generally require a full poisonings related for md medicine/dnb medicine research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.
PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.
Enquire about a poisonings related for md medicine/dnb medicine PhD or MMed proposal →🔥 Trending research areas in Poisoning for 2026–27
Current dissertation opportunities are moving towards better exposure classification, reproducible severity assessment and use of routinely available physiological and biochemical markers.
Exposure definition: State how the poison will be identified: container label, treatment record, patient or relative history, occupational exposure history, toxicology assay where available, or a predefined clinical toxidrome. Do not combine confirmed and merely suspected exposures without declaring separate categories.
Time zero: Fix the reference point for every variable, such as first assessment in the emergency department or the first blood sample before antidote administration. Lactate, pH, cholinesterase, carboxyhaemoglobin, blood pressure and consciousness may change rapidly after oxygen, fluids, atropine, ventilation or antidotes.
Dose and concentration: Reported quantity ingested is often uncertain because bottle concentration, spillage, vomiting and mixed formulations are unknown. Treat reported dose as an exposure estimate unless the formulation and concentration can be verified.
Confounding: Prespecify co-ingestants, alcohol use, chronic disease, prehospital treatment, referral delay and treatment given before sampling. These factors can alter both biomarkers and apparent severity.
Outcome definition: Choose a measurable endpoint such as need for ventilation, vasopressor requirement, acute kidney injury, intensive care admission, a validated severity category or in-hospital mortality, and define the observation window in advance.
Synopsis: The synopsis should present the research question, poison or exposure group, study design, main variables, primary outcome, approximate sample size and proposed analysis in a compact form suitable for departmental and institutional review.
Protocol: The protocol must go further by defining how exposure will be verified, how mixed or unidentified poisonings will be handled, exactly when clinical and laboratory variables will be recorded, which treatment given before sampling will be captured, and which severity or outcome definition will be used.
Why the distinction matters: A poisoning synopsis may say that serum lactate will be correlated with severity, but the full protocol must specify whether lactate is the first pre-treatment value, whether patients transferred after fluids or antidotes are eligible, and which severity scale or clinical endpoint is being correlated with it.
Define the unit of analysis: Usually the unit is one poisoning episode, not one laboratory value. If the same patient contributes more than one admission, the protocol should state whether repeat episodes will be excluded or handled as non-independent observations.
Match sample size to the primary objective: A prevalence study, a comparison of two poisoning groups, a correlation between a biomarker and severity, and a diagnostic or prognostic accuracy study require different calculations. The sample should not be justified only by the number of cases seen in the previous year.
Use the analysis that matches the data: Categorical severity groups generally require chi-square or Fisher's exact testing for categorical variables and an appropriate parametric or non-parametric comparison for continuous variables. Correlation does not establish prediction, and a significant association does not by itself establish a clinically useful cut-off.
Serial measurements need separate handling: If lactate, pH, electrocardiographic variables or organ-function markers are measured repeatedly, the protocol should define the scheduled time points and use an analysis that accounts for repeated observations rather than treating every measurement as an independent sample.
Start with poisonings that your emergency department actually sees often enough to recruit within the available data-collection period. Prefer a focused exposure group and one primary question, such as a severity association, a comparison between two clinically relevant groups or the performance of a routinely available marker. Avoid building the project around a specialised toxin assay that is rarely available or around an exposure that produces only a few cases each year.
Feasible designs include prospective or retrospective observational studies, cross-sectional analytical studies, cohort studies with an in-hospital outcome, case-control studies for selected uncommon outcomes and comparative studies between clearly defined exposure groups. Diagnostic or prognostic accuracy designs are possible when the reference outcome and follow-up pathway are defined for every enrolled patient.
Agree on the poison or exposure definition, minimum evidence required to classify a case, inclusion of mixed or unidentified poisonings, the exact assessment time point, the main severity measure, the primary outcome, expected monthly case load and which investigations are performed routinely. These decisions determine whether the project remains analysable after data collection starts.
Yes, provided the question does not require a laboratory-confirmed exposure. A retrospective study can use a prespecified combination of documented exposure history, container or prescription evidence, characteristic clinical features, treating physician diagnosis and antidote use. The limitation is misclassification, so confirmed, probable and uncertain cases should not be silently pooled as if they were equivalent.
The synopsis is the concise research plan submitted for initial academic approval. The protocol is the operational document that must define exposure classification, timing of measurements, treatment received before sampling, outcome definitions, data collection procedures, sample-size assumptions and the statistical analysis in enough detail for another researcher to reproduce the study.
Acute poisoning may involve impaired consciousness, deliberate self-harm, minors and sensitive psychiatric information. Prospective recruitment should define how consent will be obtained when the patient initially lacks capacity and how consent will be revisited after recovery where required. For participants who are children, guardian consent and child assent from about seven years should be addressed. Record-based work may qualify for a waiver of consent if approved by the ethics committee and if confidentiality safeguards are adequate.
No additional radiation, contrast study or research-only venepuncture should be added merely for the dissertation unless specifically justified and approved. If extra blood is essential, the protocol should state the volume limit and sampling schedule. Separate consent is needed for identifiable photographs or video. Incidental clinically important abnormalities, including unexpected electrocardiographic, radiological or biochemical findings, should have a named escalation pathway to the treating team. Self-harm history, substance use and medico-social details require restricted access and careful anonymisation.
Do not convert an uncertain history into a precise dose. Record exactly what is known: product name, formulation, concentration if verified, approximate quantity, route, time since exposure, vomiting, co-ingestants and the source of the information. If the agent is unidentified, use a predefined category such as suspected cholinergic, sedative, corrosive or unknown exposure only when the study question allows it. Analyses that relate a reported dose to severity should clearly label it as an estimated exposure and should not imply pharmacokinetic precision that the history cannot support.
Yes, but the documents serve different purposes. An MD or DNB synopsis is usually a bounded dissertation plan designed for completion during residency, while a PhD proposal generally requires a broader research gap, a more extensive methodology and a programme of work beyond one residency project. Gulf training pathways may also require a separate board research project or proposal under SCFHS and the Saudi Board, the Arab Board of Health Specializations, or DHP, DHA, DOH and MOHAP-linked programmes. The same clinical question can sometimes be adapted, but the required format, supervision, ethics route and institutional approval should be checked for the specific programme rather than copied directly from an Indian synopsis.
Register after the exposure definition, primary objective, outcome, sample-size basis and data-collection method have been agreed with the guide and are realistically supported by the department's case load. Registration before these points are settled often leads to amendments when recruitment starts, particularly when the chosen poison is less common than expected or the planned laboratory marker is not available consistently.
Found a topic that fits your department?
Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.
Generate your protocol